Bain Capital, LP is one of the world’s leading private multi-asset alternative investment firms with over $105 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact [email protected].

Media Contacts

  • 5.1.19
    Private Equity

    Imperial Dade to be Acquired by Bain Capital Private Equity

    JERSEY CITY, NJ, May 1, 2019 – Imperial Dade, a leading distributor of disposable food service and janitorial supplies in the U.S., Puerto Rico and the Caribbean, today announced the signing of a definitive agreement for Bain Capital Private Equity to acquire a majority stake in the company.  Imperial Dade will continue to be led by its current management team, who will remain significant...

  • 3.28.19
    Private Equity

    Maesa enters next growth phase with Bain Capital Private Equity as its new partner

    PARIS, NEW YORK, LONDON, March 28th, 2019 – Bain Capital Private Equity, a leading global private investment firm, has signed a definitive agreement to acquire a majority stake in Maesa, a global beauty brand incubator supplying leading retailers and beauty companies operating worldwide. Under this joint ownership of Bain Capital Private Equity and Maesa’s co-founders and management, the...

  • 3.5.19
    Private Equity

    FXI and Innocor Combine to Create One of the Most Innovative Foam Solutions Providers

    MEDIA, PA and RED BANK, NJ, March 5, 2019 – FXI and Innocor, two of the leading producers of polyurethane foam products, today announced the signing of a definitive merger agreement that will establish one of the most comprehensive and innovative companies in the industry. The combined company will offer a complete array of solutions and serve customers across a broad range of end markets –...

  • 2.13.19
    Private Equity

    U.S. Renal Care to be Acquired by Investor Group

    PLANO, TX, February 13, 2019 – U.S. Renal Care, Inc., a leading provider of dialysis services for patients suffering from end stage renal disease, today announced that it has entered into a definitive agreement to be acquired by a private investor group led by Chris Brengard and the U.S. Renal management team, along with Bain Capital Private Equity, Summit Partners, Revelstoke Capital Partners,...

  • 1.15.19
    Private Equity

    Brillio Announces Investment by Bain Capital Private Equity

    SANTA CLARA, CA, January 15 2019 - Brillio, a global digital technology consulting and solutions company, today announced the signing of a definitive agreement for Bain Capital Private Equity to acquire a majority stake in the company to further scale its digital transformation offerings. Brillio will continue to be led by the current management team, headed by Chief Executive Officer Raj...

  • 12.10.18
    Private Equity

    Bain-backed Italmatch Chemicals buys BWA Water Additives

    GENOA, December 10, 2018 – Italmatch Chemicals, a leading global specialty chemical group focused on the production and marketing of performance additives for water & process treatment, oil & gas, industrial lubricants and plastics, today announces that it has signed an agreement to acquire BWA Water Additives, a leading global provider of sustainable water management solutions for the...

  • 10.23.18
    Private Equity
    Life Sciences

    Bain Capital and Pfizer Create Cerevel Therapeutics, New CNS Company

    BOSTON and NEW YORK, October 23, 2018 – Bain Capital, LP and Pfizer Inc. (NYSE: PFE) today announced the creation of Cerevel Therapeutics, LLC (“Cerevel”), a new biopharmaceutical company focused on developing drug candidates to treat disorders of the central nervous system (CNS). Pfizer is contributing a portfolio of pre-commercial neuroscience assets to Cerevel, which include three...

  • 10.23.18
    Private Equity

    Dealer Tire Announces Significant Investment by Bain Capital Private Equity

    CLEVELAND, OH, October 23, 2018 — Dealer Tire, LLC, a national leader in replacement tire and parts distribution for automotive dealerships, today announced that Bain Capital Private Equity has made a significant investment in the company to accelerate growth and expansion. Financial terms of the private investment were not disclosed and proceeds will be used to purchase the interests of...

  • 10.11.18
    Private Equity

    Public delisting tender offer for the remaining STADA shares launched

    FRANKFURT/MUNICH, October 11, 2018 – Nidda Healthcare GmbH (“Nidda Healthcare”), a company controlled by funds advised by Bain Capital Private Equity (Europe), LLP (“Bain Capital”) and Cinven Partners LLP (“Cinven”), today published the offer document for the public delisting tender offer (“Offer”) for all shares of STADA Arzneimittel AG (“STADA” or the “Company”)...

  • 10.8.18
    Private Equity

    Rocket Software Announces Investment by Bain Capital Private Equity

    WALTHAM, MA, October 8, 2018 – Rocket Software, a global technology provider and leader in developing and delivering enterprise modernization and optimization solutions, today announced the signing of a definitive agreement for Bain Capital Private Equity to acquire a majority stake in the company. The enterprise value of the transaction is approximately $2 billion. Rocket Software will...

Latest @BainCapital tweets